Crescent Biopharma, Inc. (GETTEX:C68) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of ordinary shares and pre-funded warrants Closed: US$143.7M in the latest tranche · US$14.5 a share · Jefferies +4 Dealers: Jefferies (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), LifeSci Capital | Jul 30, 2026 |
| Private placement of ordinary shares and pre-funded warrants Announced: about US$185M · US$13.41 a share · Jefferies +5 Dealers: Jefferies, TD Cowen, Guggenheim Securities, Cantor, Wedbush & Co., Piper Sandler Buyers: Forbion; Fairmount; Vestal Point Capital; BVF Partners; ADAR1; Balyasny Asset Management; Venrock Healthcare Capital Partners Use of proceeds: Advance preclinical and clinical development of product candidates, working capital and general corporate purposes | Dec 4, 2025 |